Re-examining RAS-blocking treatment regimens for abrogating progression of chronic kidney disease
{{output}}
This commentary discusses the findings and profound clinical implications of a prespecified analysis of renal outcomes performed by Mann et al. in the large ONTARGET study. This study assessed the effects of the angiotensin-converting-enzyme (ACE) inhibitor ra... ...
